Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2025-06-06

PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy

View source ↗

Summary

EMA's PRAC concludes that non-arteritic anterior ischemic optic neuropathy (NAION) is a very rare side effect of semaglutide medicines Ozempic, Rybelsus, and We…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OZEMPIC (semaglutide)
  • Rybelsus (semaglutide)
  • WEGOVY (Semaglutide)

Snippet

Treatment with semaglutide should be stopped if NAION occurs